Thanks to an in-utero treatment that's never been done before, Ottawa's Ayla Bashir is developing at a rate expected of the average 17-month-old infant — even while dealing with Pompe disease, a genetic disorder that killed two of her sisters.
Thanks to an in-utero treatment that's never been done before, Ottawa's Ayla Bashir is developing at a rate expected of the average 17-month-old infant — even while dealing with Pompe disease, a genetic disorder that killed two of her sisters.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.